Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia

Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737

A systematic review of prevalence studies of dementia in Parkinson's disease

Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714

Prevalence and Characteristics of Dementia in Parkinson Disease

Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403

Rivastigmine for Dementia Associated with Parkinson's Disease

Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., Deyn, P. P. D., Durif, F., Kulisevsky, J., van Laar, T., Lees, A. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,219

Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years

Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050

Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors

Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035

Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA -associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol

Colucci, F., Avenali, M., Micco, R. D., Poli, M. F., Cerri, S., Stanziano, M., Bacila, A., Cuconato, G., Franco, V., Franciotta, D. M., et al. (2023) · BMJ Neurology Open · doi:10.1136/bmjno-2023-000535 · Cited by 44

Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson’s disease and dementia with Lewy bodies

Frigerio, I., Bouwman, M. M. A., Noordermeer, R. T. G. M. M., Podobnik, E., Popovic, M. M., Timmermans, E., Rozemüller, A. J. M., van de Berg, W. D. J., & Jonkman, L. E. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01711-w · Cited by 43

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies

Petrova, M., Mehrabian-Spasova, S., Aarsland, D., Raycheva, M. R., & Traykov, L. D. (2015) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000375363 · Cited by 45

New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease

Goetz, C. G. (2010) · Movement Disorders · doi:10.1002/mds.22636 · Cited by 45

Influence of Different Cut-Off Values on the Diagnosis of Mild Cognitive Impairment in Parkinson's Disease

Liepelt‐Scarfone, I., Graeber, S., Feseker, A., Baysal, G. Ö. D., Godau, J., Gaenslen, A., Maetzler, W., & Berg, D. (2011) · Parkinson s Disease · doi:10.4061/2011/540843 · Cited by 45

Objective Measurement of Daytime Napping, Cognitive Dysfunction and Subjective Sleepiness in Parkinson’s Disease

Bolitho, S., Naismith, S. L., Salahuddin, P., Terpening, Z., Grunstein, R. R., & Lewis, S. J. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081233 · Cited by 45

Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry

Sečník, J., Čermáková, P., Fereshtehnejad, S., Dannberg, P., Johnell, K., Fastbom, J., Winblad, B. G., Eriksdotter, M., & Religa, D. (2017) · Diabetes Care · doi:10.2337/dc16-2516 · Cited by 45

Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease

Chung, S. J., Shin, J., Cho, K. H., Lee, Y., Sohn, Y. H., Seong, J., & Lee, P. H. (2017) · Movement Disorders · doi:10.1002/mds.27106 · Cited by 45

Parkinson’s Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles

Aldridge, G. M., Birnschein, A. M., Denburg, N. L., & Narayanan, N. S. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00123 · Cited by 45

Striatal changes in Parkinson disease: An investigation of morphology, functional connectivity and their relationship to clinical symptoms

Owens‐Walton, C., Jakabek, D., Li, X., Wilkes, F., Walterfang, M., Velakoulis, D., van Westen, D., Looi, J. C., & Hansson, O. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.03.004 · Cited by 45

Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates

Orfei, M. D., Assogna, F., Pellicano, C., Pontieri, F. E., Caltagirone, C., Pierantozzi, M., Stefani, A., & Spalletta, G. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.04.015 · Cited by 45

Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study

Pilotto, A., di Cola, F. S., Premi, E., Grasso, R., Turrone, R., Gipponi, S., Scalvini, A., Cottini, E., Paghera, B., Garibotto, V., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04324-5 · Cited by 45

Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis

Wang, Q., Liu, J., Guo, Y., Dong, G., Zou, W., & Chen, Z. (2019) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20198443 · Cited by 45

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease

Lin, C., Liu, H.-C., Yang, S.-Y., Yang, K., Wu, C., & Chiu, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101601 · Cited by 45

Clinical drug development for dementia with Lewy bodies: past and present

Lee, G., Cummings, J. L., Decourt, B., Leverenz, J. B., & Sabbagh, M. N. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1681398 · Cited by 46

Cognitive impairment in Parkinson's disease: A clinical and pathophysiological overview

Brandão, P. R. D. P., Munhoz, R. P., Grippe, T. C., Cardoso, F., Castro, B. M. D. A. E., Titze‐de‐Almeida, R., Tomaz, C. A. B., & Tavares, M. C. H. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117177 · Cited by 47

APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease

Tunold, J., Geut, H., Rozemüller, A. J. M., Henriksen, S. P., Toft, M., van de Berg, W. D. J., & Pihlstrøm, L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.631145 · Cited by 49

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)

Dlay, J. K., Duncan, G. W., Khoo, T. K., Williams-Gray, C. H., Breen, D. P., Barker, R. A., Burn, D. J., Lawson, R. A., & Yarnall, A. J. (2020) · Brain Sciences · doi:10.3390/brainsci10020078 · Cited by 44

Cardiovascular Diseases in ∼30,000 Patients in the Swedish Dementia Registry

Čermáková, P., Johnell, K., Fastbom, J., Ptacek, S. G., Lund, L. H., Winblad, B. G., Eriksdotter, M., & Religa, D. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150499 · Cited by 45

The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment

Pirogovsky, E., Schiehser, D. M., Litvan, I., Obtera, K. M., Burke, M. M., Lessig, S. L., Song, D. D., Liu, L., & Filoteo, J. V. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.03.010 · Cited by 44

Cognitive impairment in Wilson's disease

Frota, N. A. F., Caramelli, P., & Barbosa, E. R. (2009) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642009dn30100004 · Cited by 44

Using The Apriori Algorithm To Classify The Care Needs Of Patients With Different Types Of Dementia

Jhang, K.-M., Chang, M.-C., Lo, T.-Y., Lin, C., Wang, W.-F., & Wu, H. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s223816 · Cited by 44

Structural and Functional Thalamic Changes in Parkinson's Disease With Mild Cognitive Impairment

Li, M., He, J., Liu, X., Wang, Z., Lou, X., & Ma, L. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27195 · Cited by 44

Parkinson disease clinical subtypes: key features & clinical milestones

Campbell, M. C., Myers, P. S., Weigand, A. J., Foster, E. R., Cairns, N. J., Jackson, J. J., Lessov‐Schlaggar, C. N., & Perlmutter, J. S. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51102 · Cited by 44

Factor analysis–derived cognitive profile predicting early dementia conversion in PD

Chung, S. J., Lee, H. S., Kim, H.-R., Yoo, H. S., Lee, Y. H., Jung, J. H., Baik, K., Ye, B. S., Sohn, Y. H., & Lee, P. H. (2020) · Neurology · doi:10.1212/wnl.0000000000010347 · Cited by 44

Neuropsychiatric Symptoms and Functional Decline in Alzheimerʼs Disease and Lewy Body Dementia

Borda, M. G., Aarsland, D., Tovar, D., Giil, L. M., Ballard, C. G., González, M. C., Brønnick, K., Alves, G. W., Oppedal, K., Soennesyn, H., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16709 · Cited by 46

Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease

Zerr, I., Villar‐Piqué, A., Hermann, P., Schmitz, M., Varges, D., Ferrer, I., Riggert, J., Zetterberg, H., Blennow, K., & Llorens, F. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00815-6 · Cited by 46

Aquaporin-4 Polymorphisms Are Associated With Cognitive Performance in Parkinson’s Disease

Fang, Y., Dai, S., Jin, C., Si, X., Gu, L., Song, Z., Gao, T., Chen, Y., Yan, Y., Yin, X., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.740491 · Cited by 43

The effect of small vessel disease on motor and cognitive function in Parkinson’s disease

Shibata, K., Sugiura, M., Nishimura, Y., & Sakura, H. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.04.029 · Cited by 43

Effectiveness of Cognitive Rehabilitation in Parkinson’s Disease: A Systematic Review and Meta-Analysis

Luengos, I. S., Balboa-Bandeira, Y., Lucas‐Jiménez, O., Ojeda, N., Peña, J., & Ibarretxe‐Bilbao, N. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050429 · Cited by 46

Validation of the Spanish version of Addenbrooke's Cognitive Examination III for diagnosing dementia

Matías‐Guiu, J. A., de Bobadilla, R. F., Escudero, G., Pérez‐Pérez, J., Cortés, A., Morenas‐Rodríguez, E., Valles‐Salgado, M., Moreno‐Ramos, T., Kulisevsky, J., & Matías‐Guiu, J. (2015) · Neurología (English Edition) · doi:10.1016/j.nrleng.2014.05.001 · Cited by 43

Divergent functional connectivity during attentional processing in Lewy body dementia and Alzheimer's disease

Kobeleva, X., Firbank, M., Peraza, L. R., Gallagher, P., Thomas, A. J., Burn, D. J., O'Brien, J. T., & Taylor, J. (2017) · Cortex · doi:10.1016/j.cortex.2017.02.016 · Cited by 42

Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study

Nicoletti, A. S. Q., Luca, A., Baschi, R., Cicero, C. E., Mostile, G., Davì, M., Bianca, G. L., Restivo, V., Zappia, M., & Monastero, R. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10189-8 · Cited by 43

Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia

Miller, R. L., Dhavale, D. D., O’Shea, J. Y., Andruska, K. M., Liu, J., Franklin, E. E., Buddhala, C., Loftin, S. K., Cirrito, J. R., Perrin, R. J., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51482 · Cited by 43

Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination

Vásquez, K. A., Miranda‐Valverde, E., Aguilar, D. V., & Hernández-Gabarain, H.-J. (2019) · Dementia & Neuropsychologia · doi:10.1590/1980-57642018dn13-010008 · Cited by 42

The Impact of the COVID-19 Pandemic on Alzheimer's Disease and Other Dementias

Gan, J., Liu, S., Wu, H., Chen, Z., Fei, M., Xu, J., Dou, Y., Wang, X., & Ji, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.703481 · Cited by 42

Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology

Pihlstrøm, L., Shireby, G. L., Geut, H., Henriksen, S. P., Rozemüller, A. J. M., Tunold, J., Hannon, E. J., Francis, P. T., Thomas, A. J., Love, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32619-z · Cited by 42

Glymphatic function from diffusion-tensor MRI to predict conversion from mild cognitive impairment to dementia in Parkinson’s disease

Pang, H., Wang, J., Yu, Z., Hong-mei, Y., Li, X., Bu, S., Zhao, M., Jiang, Y., Liu, Y., & Fan, G. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12525-8 · Cited by 42

Pathologic Correlates of Dementia in Individuals with Lewy Body Disease

Sonnen, J. A., Postupna, N. O., Larson, E. B., Crane, P. K., Rose, S. E., Montine, K. S., Leverenz, J. B., & Montine, T. J. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00371.x · Cited by 42

Is all cognitive impairment in Parkinson’s disease “mild cognitive impairment”?

Martínez‐Horta, S., & Kulisevsky, J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0675-9 · Cited by 43

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)

Fereshtehnejad, S.-M., Religa, D., Westman, Lökk, J., Eriksdotter, M., & Aarsland, D. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45840 · Cited by 42

Enfermedad de Parkinson avanzada. Características clínicas y tratamiento. Parte II

Kulisevsky, J., Luquín, M. R., Arbelo, J. M., Burguera, J. A., Carrillo, F., Castro, A., Chacón, J., Ruiz, P., Lezcano, E., Mir, P., et al. (2013) · Neurología · doi:10.1016/j.nrl.2013.05.002 · Cited by 43

The role of the right dorsolateral prefrontal cortex in the Tower of London task performance: repetitive transcranial magnetic stimulation study in patients with Parkinson’s disease

Srovnalová, H., Mareček, R., Kubíková, R., & Rektorová, I. (2012) · Experimental Brain Research · doi:10.1007/s00221-012-3255-9 · Cited by 46

Generalization of Youden index for multiple‐class classification problems applied to the assessment of externally validated cognition in Parkinson disease screening

Nakas, C. T., Dalrymple‐Alford, J. C., Anderson, T., & Alonzo, T. A. (2012) · Statistics in Medicine · doi:10.1002/sim.5592 · Cited by 42

Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson’s Disease Patients

Wood, R. A., Hopkins, S. A., Moodley, K. K., & Chan, D. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00263 · Cited by 42

Meta-Analysis of the Relationship between the APOE Gene and the Onset of Parkinson’s Disease Dementia

Pang, S., Li, J., Zhang, Y., & Chen, J. (2018) · Parkinson s Disease · doi:10.1155/2018/9497147 · Cited by 47

Does outpatient palliative care improve patient-centered outcomes in Parkinson's disease: Rationale, design, and implementation of a pragmatic comparative effectiveness trial

Kluger, B. M., Katz, M., Galifianakis, N. B., Pantilat, S. Z., Kutner, J. S., Sillau, S., Gritz, M., Jones, J., Fairclough, D. L., Sumrall, M., et al. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.02.005 · Cited by 42

The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson's disease

Dulski, J., Schinwelski, M. J., Konkel, A., Grabowski, K., Libionka, W., Wąż, P., Sitek, E. J., & Sławek, J. W. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.04.001 · Cited by 42

Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures

Kim, H. M., Nazor, C., Zabetian, C. P., Quinn, J. F., Chung, K. A., Hiller, A., Hu, S., Leverenz, J. B., Montine, T. J., Edwards, K. L., et al. (2019) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2019.08.006 · Cited by 42

Weighted network measures reveal differences between dementia types: An EEG study

Mehraram, R., Kaiser, M., Cromarty, R. A., Graziadio, S., O'Brien, J. T., Killen, A., Taylor, J., & Peraza, L. R. (2019) · Human Brain Mapping · doi:10.1002/hbm.24896 · Cited by 43

Cerebello-basal ganglia connectivity fingerprints related to motor/cognitive performance in Parkinson's disease.

Kawabata, K., Watanabe, H., Bagarinao, E., Ohdake, R., Hara, K., Ogura, A., Masuda, M., Kato, T., Tsuboi, T., Maesawa, S., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.09.005 · Cited by 35

Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson’s disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysis

Pezzoli, S., Sánchez‐Valle, R., Solanes, A., Kempton, M. J., Bandmann, O., Shin, J. I., Cagnin, A., Goldman, J. G., Merkitch, D., Firbank, M., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.030 · Cited by 42

Biomarkers of Parkinson's disease and Dementia with Lewy bodies

Henchcliffe, C., Dodel, R. C., & Beal, M. F. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.002 · Cited by 42

Cognitive impairment and dementia in Parkinson's disease

Marder, K. S. (2010) · Movement Disorders · doi:10.1002/mds.22787 · Cited by 43

The α-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease

McGeer, P. L., & McGeer, E. G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.008 · Cited by 41

Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacy

Lench, D. H., Turner, T. H., McLeod, C., Boger, H. A., Lovera, L., Heidelberg, L., Elm, J., Phan, A. N. B., Badran, B. W., & Hinson, V. K. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1210103 · Cited by 43

Longitudinal Assessment of the Pattern of Cognitive Decline in Non-Demented Patients with Advanced Parkinson's Disease

Gasca‐Salas, C., Estanga, A., Clavero, P., Aguilar‐Palacio, I., Gonzalez-Redondo, R., Obeso, J. A., & Rodríguez-Oroz, M. C. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-140398 · Cited by 49

Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction

Saka, E., & Elibol, B. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.04.008 · Cited by 41

A three dimensional anatomical view of oscillatory resting-state activity and functional connectivity in Parkinson's disease related dementia: An MEG study using atlas-based beamforming

Ponsen, M. M., Stam, C. J., Bosboom, J. L. W., Berendse, H. W., & Hillebrand, A. (2012) · NeuroImage Clinical · doi:10.1016/j.nicl.2012.11.007 · Cited by 41

Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are More Similar to Alzheimer’s Disease than Dementia with Lewy Bodies: A Case-Control Study

Chiu, P., Tsai, C., Chen, P.-K., Chen, W.-J., & Lai, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153989 · Cited by 41

Aldehyde dehydrogenase 2 is associated with cognitive functions in patients with Parkinson’s disease

Yu, R., Tan, C., Lu, Y.-C., & Wu, R. (2016) · Scientific Reports · doi:10.1038/srep30424 · Cited by 42

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies

Llorens, F., Schmitz, M., Varges, D., Kruse, N., Gotzmann, N., Gmitterová, K., Mollenhauer, B., & Zerr, I. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8259-0 · Cited by 40

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies

Weil, R. S., Lashley, T., Brás, J., Schrag, A. E., & Schott, J. M. (2017) · F1000Research · doi:10.12688/f1000research.11725.1 · Cited by 41

The relation between plasma α-synuclein level and clinical symptoms or signs of Parkinson's disease

Malec‐Litwinowicz, M., Plewka, A., Plewka, D., Bogunia, E., Morek, M., Szczudlik, A., Szubiga, M., & Rudzińska, M. (2017) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2017.11.009 · Cited by 40

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson’s Disease

Uribe, C., Segura, B., Baggio, H. C., Campabadal, A., Abós, A., Compta, Y., Martı́, M. J., Valldeoriola, F., Bargalló, N., & Junqué, C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00325 · Cited by 41

Care Burden and Mental Ill Health in Spouses of People With Parkinson Disease Dementia and Lewy Body Dementia

Vatter, S., Stanmore, E., Clare, L., McDonald, K. R., McCormick, S. A., & Leroi, I. (2019) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719853043 · Cited by 41

Patterns of olfactory functional networks in Parkinson's disease dementia and Alzheimer's dementia

Lee, Y. H., Bak, Y., Park, C.-H., Chung, S. J., Yoo, H. S., Baik, K., Jung, J. H., Sohn, Y. H., Shin, N., & Lee, P. H. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.021 · Cited by 41

Caregiver Burden in Late-Stage Parkinsonism and Its Associations

Kalampokini, S., Hommel, A. L. A. J., Lorenzl, S., Ferreira, J. J., Meissner, W. G., Odin, P., Bloem, B. R., Dodel, R. C., & Schrag, A. E. (2020) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720968263 · Cited by 41

Resting-state EEG alpha/theta ratio related to neuropsychological test performance in Parkinson’s Disease

Jaramillo-Jiménez, A., Suárez-Revelo, J. X., Ochoa-Gómez, J. F., Arroyave, J. A. C., Bocanegra, Y., Lopera, F. J., Buriticá, O., Pineda-Salazar, D. A., Gómez, L. M., Tobón, C., et al. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.01.001 · Cited by 41

RNA-sequencing of peripheral blood circular RNAs in Parkinson disease

Kong, F., Lv, Z., Wang, L., Zhang, K., Cai, Y., Ding, Q., Sun, Z., Zhen, H., Jiao, F., Ma, Q., et al. (2021) · Medicine · doi:10.1097/md.0000000000025888 · Cited by 40

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial

Biglan, K., Munsie, L. M., Svensson, K. A., Ardayfio, P. A., Pugh, M., Sims, J. R., & Bryś, M. (2021) · Movement Disorders · doi:10.1002/mds.28879 · Cited by 41

Chapter 11 Lewy Body Dementia

Hanson, J. C., & Lippa, C. F. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)00411-5 · Cited by 41

Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging

Dugger, B. N., Serrano, G. E., Sue, L. I., Walker, D. G., Adler, C. H., Shill, H. A., Sabbagh, M. N., Caviness, J. N., Hidalgo, J., Saxon‐LaBelle, M., et al. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-2012-11073 · Cited by 42

Parkinson’s Disease: Cognitive Impairment

Mack, J., & Marsh, L. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20160043 · Cited by 48

Longitudinal Changes in Cognition in Parkinson’s Disease with and without Dementia

Johnson, D. K., & Galvin, J. E. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000323570 · Cited by 40

White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations

Agosta, F., Kostić, V., Davidović, K., Kresojević, N. D., Sarro, L., Svetel, M. V., Stanković, I., Comı, G., Klein, C., & Filippi, M. (2013) · Movement Disorders · doi:10.1002/mds.25397 · Cited by 40

Altered Resting-State Functional Connectivity of the Striatum in Parkinson's Disease after Levodopa Administration

Yang, W., Liu, B., Huang, B., Huang, R., Wang, L., Zhang, Y., Zhang, X., & Wu, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161935 · Cited by 40

Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study

Schwertner, E., Sečník, J., Ptacek, S. G., Johansson, B. A., Nägga, K., Eriksdotter, M., Winblad, B. G., & Religa, D. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.12.019 · Cited by 42

The structural connectivity of discrete networks underlies impulsivity and gambling in Parkinson’s disease

Mosley, P. E., Paliwal, S., Robinson, K., Coyne, T. J., Silburn, P. A., Tittgemeyer, M., Stephan, K. E., Breakspear, M. J., & Perry, A. (2019) · Brain · doi:10.1093/brain/awz327 · Cited by 44

Exploring the Connection between Porphyromonas gingivalis and Neurodegenerative Diseases: A Pilot Quantitative Study on the Bacterium Abundance in Oral Cavity and the Amount of Antibodies in Serum

Franciotti, R., Pignatelli, P., Carrarini, C., Romei, F. M., Mastrippolito, M., Gentile, A., Mancinelli, R., Fulle, S., Piattelli, A., ONOFRJ, M. C., et al. (2021) · Biomolecules · doi:10.3390/biom11060845 · Cited by 40

Apathy and Related Executive Syndromes in Dementia Associated with Parkinson’s Disease and in Alzheimer’s Disease

Grossi, D., Santangelo, G., Barbarulo, A. M., Vitale, C., Castaldo, G., Proto, M. G., Siano, P., Barone, P., & Trojano, L. (2013) · Behavioural Neurology · doi:10.1155/2013/781029 · Cited by 40

Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis

Wong, Y. Y., Wu, C., Yu, D., Kim, E., Wong, M., Elez, R., Zebarth, J., Ouk, M., Tan, J., Liao, J., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.06.004 · Cited by 41

Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost

Kandiah, N., Wang, V., Lin, X., Mei, N. M., Lim, L. L. H., Ng, A. S. L., Hameed, S., & Wee, H. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150471 · Cited by 40

99mTc‐ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson’s disease patients: a correlation with neuropsychological tests

Chang, C.-C., Liu, J. ‐., Chang, Y., Chang, W. ‐., Chen, S., & Lee, C. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.02001.x · Cited by 40

Differences in quantitative methods for measuring subjective cognitive decline – results from a prospective memory clinic study

Vogel, A., Salem, L. C., Andersen, B. B., & Waldemar, G. (2016) · International Psychogeriatrics · doi:10.1017/s1041610216000272 · Cited by 40

Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias

Fields, J. A. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx085 · Cited by 40

Parkinson’s Disease and Other Movement Disorders

Gunzler, S. A., Schoenberg, M. R., Riley, D. E., Walter, B. L., Sweet, J. A., & Maciunas, R. J. (2010) · Springer eBooks · doi:10.1007/978-0-387-76978-3_19 · Cited by 40

Interoceptive processing deficit: A behavioral marker for subtyping Parkinson's disease

Santangelo, G., Vitale, C., Baiano, C., D'Iorio, A., Longo, K., Barone, P., Amboni, M., & Conson, M. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.05.001 · Cited by 39

Caregiver Burden in Parkinson Disease with Dementia Compared to Alzheimer Disease in Korea

Shin, H., Youn, J., Kim, J. S., Lee, J.-Y., & Cho, J. W. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712464819 · Cited by 38

Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus

Sakurai, A., Tsunemi, T., Ishiguro, Y., Okuzumi, A., Hatano, T., & Hattori, N. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10778-1 · Cited by 39

Resting‐State Functional Connectivity in Frontostriatal and Posterior Cortical Subtypes in Parkinson's Disease‐Mild Cognitive Impairment

Devignes, Q., Bordier, C., Viard, R., Defebvre, L., Kuchcinski, G., Leentjens, A. F. G., Lopes, R., & Dujardin, K. (2021) · Movement Disorders · doi:10.1002/mds.28888 · Cited by 40

Predicting cognitive decline in Parkinson’s disease using FDG-PET–based supervised learning

Booth, S., Park, K. W., Lee, C. S., & Ko, J. H. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157074 · Cited by 39

CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease

Barba, L., Abu‐Rumeileh, S., Halbgebauer, S., Bellomo, G., Paoletti, F. P., Gaetani, L., Oeckl, P., Steinacker, P., Massa, F., Parnetti, L., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207371 · Cited by 39

Memantine improves goal attainment and reduces caregiver burden in Parkinson's disease with dementia

Leroi, I., Atkinson, R., & Overshott, R. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4077 · Cited by 39

Cumulative exposure to lead and cognition in persons with Parkinson's disease

Weuve, J., Press, D. Z., Grodstein, F., Wright, R. O., Hu, H., & Weisskopf, M. G. (2012) · Movement Disorders · doi:10.1002/mds.25247 · Cited by 39

Gait and cognition in Parkinson’s disease: implications for rehabilitation

Iansek, R., Danoudis, M. E., & Bradfield, N. I. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0006 · Cited by 39

Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson׳s disease

Pontieri, F. E., Assogna, F., Pellicano, C., Cacciari, C., Pannunzi, S., Morrone, A., Danese, E., Caltagirone, C., & Spalletta, G. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.006 · Cited by 39

Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism

Park, H.-E., Park, I.-S., Oh, Y., Yang, D., Lee, K.-S., Choi, H. S., Ahn, K. J., & Kim, J. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.03.046 · Cited by 39

Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia

Maetzler, W., Tian, Y., Baur, S. M., Gauger, T., Odoj, B., Schmid, B., Schulte, C., Deuschle, C., Heck, S. A., Apel, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048042 · Cited by 42

Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients

Merola, A., Rizzi, L., Artusi, C. A., Zibetti, M., Rizzone, M. G., Romagnolo, A., Bernardini, A., Lanotte, M., & Lopiano, L. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7414-8 · Cited by 39

Dementia in Parkinson's Disease

Burn, D. J. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00012-x · Cited by 17

Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis

Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 232

Diagnosis and Treatment of Parkinson's Disease Dementia : An Update

Park, M. Y. (2007) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2007.24.2s.s159

Clinical phenotype of Parkinson disease dementia

Galvin, J. E., Pollack, J., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242630.52203.8f · Cited by 264

Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria

Martínez‐Martín, P., Falup‐Pecurariu, C., Rodríguez‐Blázquez, C., Serrano‐Dueñas, M., Artal, F. J. C., Rojo-Abuín, J. M., & Aarsland, D. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.05.017 · Cited by 64